Allergy

Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
pp. 1237-1245(9)
Authors: Niedoszytko, M.; de Monchy, J.; van Doormaal, J. J.; Jassem, E.; Oude Elberink, J. N. G.

Factors influencing the incidence and prevalence of food allergy
pp. 1246-1255(10)
Authors: Cochrane, S.; Beyer, K.; Clausen, M.; Wjst, M.; Hiller, R.; Nicoletti, C.; Szepfalusi, Z.; Savelkoul, H.; Breiteneder, H.; Manios, Y.; Crittenden, R.; Burney, P.

EAACI/GA²LEN task force consensus report: the autologous serum skin test in urticaria
pp. 1256-1268(13)
Authors: Konstantinou, G. N.; Asero, R.; Maurer, M.; Sabroe, R. A.; Schmid-Grendelmeier, P.; Grattan, C. E. H.

Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-γ in patients with delayed-type drug hypersensitivity
pp. 1269-1278(10)
Authors: Lochmatter, P.; Beeler, A.; Kawabata, T. T.; Gerber, B. O.; Pichler, W. J.

Neuropsychologic status at the age 4 years and atopy in a population-based birth cohort
pp. 1279-1285(7)
Authors: Julvez, J.; Torrent, M.; Guxens, M.; Antó, J. M.; Guerra, S.; Sunyer, J.

A haplotype in the inducible T-cell tyrosine kinase is a risk factor for seasonal allergic rhinitis
pp. 1286-1291(6)
Authors: Benson, M.; Mobini, R.; Barrenäs, F.; Halldén, C.; Naluai, Å. T.; Säll, T.; Cardell, L. O.

Nasal CpG oligodeoxynucleotide administration induces a local inflammatory response in nonallergic individuals
pp. 1292-1300(9)
Authors: Månsson, A.; Bachar, O.; Adner, M.; Cardell, L.-O.

Genes regulating molecular and cellular functions in noninfectious nonallergic rhinitis
pp. 1301-1308(8)
Authors: Cardell, L. O.; Andersson, M.; Cervin, A.; Davidsson, Å.; Hellgren, J.; Holmström, M.; Lundblad, L.; Stierna, P.; Stjärne, P.; Adner, M.

Differential requirements for interleukin (IL)-4 and IL-13 in protein contact dermatitis induced by Anisakis
pp. 1309-1318(10)
Authors: Nieuwenhuizen, N.; Herbert, D. R.; Brombacher, F.; Lopata, A. L.

The basophil activation test in the diagnosis of allergy: technical issues and critical factors
pp. 1319-1326(8)
Authors: Sturm, G. J.; Kranzelbinder, B.; Sturm, E. M.; Heinemann, A.; Groselj-Strele, A.; Aberer, W.

Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life
pp. 1327-1332(6)
Authors: Chen, C.-M.; Weidinger, S.; Klopp, N.; Sausenthaler, S.; Bischof, W.; Herbarth, O.; Bauer, M.; Borte, M.; Schaaf, B.; Lehmann, I.; Behrendt, H.; Krämer, U.; Berdel, D.; von Berg, A.; Bauer, C. P.; Koletzko, S.; Illig, T.; Wichmann, H.-E.; Heinrich, J.

Opposite gene by environment interactions in Karelia for CD14 and CC16 single nucleotide polymorphisms and allergy
pp. 1333-1341(9)
Authors: Zhang, G.; Khoo, S.-K.; Laatikainen, T.; Pekkarinen, P.; Vartiainen, E.; von Hertzen, L.; Hayden, C. M.; Goldblatt, J.; Mäkelä, M.; Haahtela, T.; Le Souëf, P. N.

Ambient ozone modifies the effect of tumor necrosis factor G-308A on bronchitic symptoms among children with asthma
pp. 1342-1348(7)
Authors: Lee, Y.-L.; McConnell, R.; Berhane, K.; Gilliland, F. D.

The effects of selected probiotic strains on the development of eczema (the PandA study)
pp. 1349-1358(10)
Authors: Niers, L.; Martín, R.; Rijkers, G.; Sengers, F.; Timmerman, H.; van Uden, N.; Smidt, H.; Kimpen, J.; Hoekstra, M.

Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up
pp. 1359-1365(7)
Authors: Valkonen, H.; Waris, M.; Ruohola, A.; Ruuskanen, O.; Heikkinen, T.

Mite serine protease activates protease-activated receptor-2 and induces cytokine release in human keratinocytes
pp. 1366-1374(9)
Authors: Kato, T.; Takai, T.; Fujimura, T.; Matsuoka, H.; Ogawa, T.; Murayama, K.; Ishii, A.; Ikeda, S.; Okumura, K.; Ogawa, H.

Serum interleukin-17 levels are related to clinical severity in allergic rhinitis
pp. 1375-1378(4)
Authors: Ciprandi, G.; De Amici, M.; Murdaca, G.; Fenoglio, D.; Ricciardolo, F.; Marseglia, G.; Tosca, M.

How much specific is the association between hymenoptera venom allergy and mastocytosis?
pp. 1379-1382(4)
Authors: Bonadonna, P.; Zanotti, R.; Pagani, M.; Caruso, B.; Perbellini, O.; Colarossi, S.; Olivieri, E.; Dama, A.; Schiappoli, M.; Senna, G.; Antico, A.; Passalacqua, G.

FCER1A genetic variability and serum IgE levels
pp. 1383-1383(1)
Authors: Potaczek, D. P.; Okumura, K.; Nishiyama, C.

Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis
pp. 1384-1385(2)
Authors: Kontou-Fili, K.; Filis, C. I.

The HLA allele marker for differentiating ASA hypersensitivity phenotypes
pp. 1385-1387(3)
Authors: Lee, H.-Y.; Lee, J.-W.; Lee, K.-W.; Park, M.-H.; Park, H.-S.

Treatment of acquired cold urticaria with rupatadine
pp. 1387-1388(2)
Authors: Di Leo, E.; Nettis, E.; Cassano, N.; Foti, C.; Delle Donne, P.; Vena, G.A.; Vacca, A.

Immediate allergic reaction to atropine in ophthalmic solution confirmed by basophil activation test
pp. 1388-1389(2)
Authors: Cabrera-Freitag, P.; Gastaminza, G.; Goikoetxea, M. J.; Lafuente, A.; de la Borbolla, J. M.; Sanz, M. L.

Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
pp. 1389-1390(2)
Authors: Cazzola, M.; Mura, M.; Segreti, A.; Mattei, M. A.; Rogliani, P.

Occupational asthma and rhinitis induced by a cephalosporin intermediate product: description of a case
pp. 1390-1391(2)
Authors: Pala, G.; Pignatti, P.; Perfetti, L.; Cosentino, R.; Moscato, G.

A case of occupational asthma caused by inhalation of vancomycin powder
pp. 1391-1392(2)
Authors: Choi, G.-S.; Sung, J.-M.; Lee, J.-W.; Ye, Y.-M.; Park, H.-S.

Erratum
pp. 1393-1393(1)

Erratum
pp. 1393-1393(1)

Erratum
pp. 1393-1393(1)

Erratum
pp. 1393-1393(1)

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
pp. 1394-1401(8)
Authors: Ott, H.; Sieber, J.; Brehler, R.; Fölster-Holst, R.; Kapp, A.; Klimek, L.; Pfaar, O.; Merk, H.

House dust mite allergy: complete removal of the provoking allergen is a primary therapeutic approach
pp. 1402-1403(2)
Authors: Kopp, M. V.; Niggemann, B; Forster, J

House dust mite control measures for asthma
pp. 1404-1404(1)
Authors: De Blay, F.; Barnig, C.; Ott, M.

Author's reply on: `House dust mite control measures for asthma'
pp. 1405-1405(1)
Authors: Gøtzsche, P. C.; Johansen, H. K.